Issue Date: March 24, 2014
FDA Bans Another Indian Drug Plant
Continuing a crackdown against shoddy foreign drug manufacturing, the U.S. Food & Drug Administration has again banned imports of pharmaceuticals made at a facility in India.
The latest action targets a Sun Pharmaceutical Industries plant in Karkhadi, Gujarat, that produces the antibiotic cephalosporin. Sun is one of India’s largest drug producers.
According to Sun, FDA’s action took place after a recent inspection of the facility during which agency officials identified instances . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society